Genome-wide analysis of oral squamous cell carcinomas revealed over expression of ISG15, Nestin and WNT11

Oral Diseases

Volumn 18, Issue 5, 2012, Pages 469-476

  Vincent Chong, V K ^a   Ismail, S M ^a   Rahman, Z A A ^a   Sharifah, N A ^b   Anwar, A ^c   Pradeep, P J ^a   Ramanathan, A ^a   Karen Ng, L P ^a   Kallarakkal, T G ^a   Mustafa, W M W ^d   Abraham, M T ^d   Tay, K K ^d   Zain, R B ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^c Sengenics Sdn Bhd   (Malaysia)

^d MINISTRY OF HEALTH   (Malaysia)

Author keywords

Array comparative genomic hybridization; ISG15; Nestin; Oral cancer; WNT11

Indexed keywords

INTERFERON STIMULATED GENE FACTOR 15; MESSENGER RNA; NESTIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT11 PROTEIN;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE MAPPING; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC SCREENING; GENOME; HUMAN; HUMAN TISSUE; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CARCINOMA, SQUAMOUS CELL; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOKINES; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UBIQUITINS; WNT PROTEINS;

EID: 84861985855     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01894.x     Document Type: Article

References (38)

1. Albertson DG (2006). Gene amplification in cancer. Trends Genet 22: 447-455.
2. Ambatipudi S, Gerstung M, Gowda R et al (2011). Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. PLoS ONE 6: e17250.
3. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL (2005). Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561-7567.
4. Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I (2000). Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157: 369-375.
5. Chi YH, Jeang KT (2008). Chromosomal instability and human T cell leukemia virus 1 transformation. In: Nicholas J, Jeang KT, Wu TC, eds. In human cancer viruses. Principles of transformation and pathogenesis. Volume 1, Karger: Basel, pp. 228-238.
6. 18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol Cell Proteomics 8: 1453-1474.
7. Chiou SH, Yu CC, Huang CY et al (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095.
8. Choi S, Myers JN (2008). Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87: 14-32.
9. Desai SD, Haas AL, Wood LM et al (2006). Elevated expression of ISG15 in tumor cells interferes with the Ubiquitin/26S Proteasome pathway. Cancer Res 66: 921-928.
10. Desai SD, Wood LM, Tsai YC et al (2008). ISG15 as a novel tumor biomarker for drug sensitivity. Mol Cancer Ther 7: 1430-1439.
11. Estilo CL, O-charoenrat P, Talbot S et al (2009). Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 9: 1-13.
12. Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL (2003). Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res 63: 8582-8585.
13. Garnis C, Campbell J, Zhang L, Rosin MP, Lam WL (2004). OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 40: 511-519.
14. Inazawa J, Inoue J, Imoto I (2004). Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 95: 559-563.
15. Ishiwata T, Matsuda Y, Naito Z (2011). Nestin in gastrointestinal and other cancers: Effects on cells and tumor angiogenesis. World J Gastroenterol 17: 409-418.
16. James LA (1999). Comparative genomic hybridization as a tool in tumor cytogenetics. J Pathol 187: 385-395.
17. Jarvinen AK, Autio R, Kilpinen S et al (2008). High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosom Cancer 47: 500-509.
18. Kirikoshi H, Sekihara H, Katoh M (2001). Molecular cloning and characterization of human WNT11. Int J Mol Med 8: 651-656.
19. Kleeberger W, Steven Bova G, Nielsen ME et al (2007). Roles for stem cell-Associated intermediate filament nestin in prostate cancer migration and metastasis. Cancer Res 67: 9199-9206.
20. Lee EH, Chari R, Lam A et al (2008). Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma. Clin Med Oncol 2: 169-179.
21. Li J, Wang K, Jensen TD, Li S, Bolund L, Wiuf C (2010). Tumor heterogeneity in neoplasms of breast, colon, and skin. BMC Res Notes 3: 321.
22. Lockwood WW, Chari R, Chi B, Lam WL (2006). Recent advances in array comparative genomic hybridization technologies and their applications in human genetics. Eur J Hum Genet 14: 139-148.
23. Matsuyama Y, Suzuki M, Arima C et al (2011). Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas. Mol Carcinog 50: 301-309.
24. Mitelman F, Johansson B, Mandahl N, Mertens F (1997). Clinical significance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet 95: 1-8.
25. Mochizuki S, Okada Y (2007). ADAMs in cancer cell proliferation and progression. Cancer Sci 98: 621-628.
26. Negrini S, Gorgoulis VG, Halazonetis TD (2010). Reviews: genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220-228.
27. Pathare SM, Gerstung M, Beerenwinkel N et al (2011). Clinicopathological and prognostic implications of genetic alterations in oral cancers. Oncol Lett 2: 445-451.
28. Pinkel D, Albertson DG (2005). Array comparative genomic hybridization and its applications in cancer. Nat Genet 37(Suppl): 11-17.
29. Przybytkowski E, Ferrario C, Basik M (2011). The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome. BMC Med Genomics 4: 16.
30. Rolletschek A, Kania G, Wobus AM (2006). Generation of pancreatic insulin-producing cells from embryonic stem cells-'Proof of principle', but questions still unanswered. Diabetologia 49: 2541-2545.
31. Sankaranarayanan R (2003). Human cancers by organ site: head and neck cancer. In: Stewart BW, Kleihues P, eds. In world cancer report. IARC Press: Lyon, pp. 232-236.
32. Shete S, Hosking FJ, Robertson LB et al (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
33. Silverman S (2001). Demographics and occurrence of oral and pharyngeal cancer: the outcomes, the trends, the challenge. J Am Dent Assoc 132: 7S-11S.
34. Snijders AM, Schmidt BL, Fridlyand J et al (2005). Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24: 4232-4242.
35. Sobin LH, Fleming ID (1997). TNM classification of malignant tumors, 5th edition. Cancer 80: 1803-1804.
36. Toyama T, Lee HC, Koga H, Wands JR, Kim M (2010). Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res 8: 254-265.
37. Uysal-Onganer P, Kawano Y, Caro M et al (2010). Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells. Mol Cancer 9: 55.
38. Venkatraman ES, Olshen AB (2007). A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23: 657-663.